#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cholestatic pruritus Mantle cell lymphoma recurrent Follicular lymphoma stage III Primary immunodeficiency syndrome Neurodegenerative disorder Pancreatic carcinoma Anti-myelin-associated glycoprotein antibodies positive Anti-glomerular basement membrane disease Hidradenitis Cholangitis sclerosing T-cell type acute leukaemia Acute myeloid leukaemia Aspergillus infection Neuropathy peripheral Primary mediastinal large B-cell lymphoma More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranous – Trials in Disease Anaplastic thyroid cancer – Treatment Vascular malformation – Treatment Haemophilia – Treatment Lymphangiosarcoma – Diagnostics IgA nephropathy – Life with Disease Medulloblastoma – Diagnostics Hereditary neuropathic amyloidosis – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Angiosarcoma non-metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Octreotide ATIGOTATUG Emrusolmin METAMIZOLE SODIUM Ocrelizumab Ag13909 Tofersen Teprenone Perampanel FLUORIDE Pyridoxine Antithymocyte Immunoglobulin PIROXICAM Macitentan Saruparib Sar-443579 Cimetidine Faricimab Melphalan POLYSORBATE 80 More therapies…

    Learn about Your Condition

    Oesophagectomy Pancreatitis chronic Triple positive breast cancer Brain injury B-cell lymphoma refractory Tympanic membrane hyperaemia Trigeminal neuralgia Appendicitis perforated Factor VIII deficiency Traumatic pain Cardiogenic shock Post procedural swelling Haemorrhagic stroke Small intestine leiomyosarcoma Labour induction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Smoking cessation therapy

  • Study on the Safety and Effectiveness of Cytisinicline for Helping Smokers Quit

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cytisinicline
    Spain
  • Study on Cytisine for Quitting Nicotine E-Cigarettes and Tobacco in Motivated Individuals

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cytisine
    Poland
  • Study on Using Nicotine Electronic Cigarettes and Varenicline for Smoking Cessation in Smokers of 10+ Cigarettes Daily

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Varenicline
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!